title: Superior results with combined kidney-pancreas transplants.
abstract: From February of 1987 to February of 1991 the authors performed 23 pancreas transplants for Type I diabetes mellitus. Eight of the pancreas transplants were in patients who had a previous kidney transplant, 14 were simultaneous kidney and pancreas transplants, and 1 was in a pre-uremic diabetic. Two patients have been retransplanted after losing first grafts. All pancreata were retrieved from heart-beating cadaver donors. Pancreata were transplanted into the iliac fossa of the recipient using the iliac artery and vein as arterial inflow and venous outflow, respectively. Drainage of the pancreatic ductal system was accomplished by anastomosing either a patch or segment of duodenum surrounding the ampulla of Vater to the urinary bladder. All pancreata functioned initially with no patient requiring insulin 6 hours after surgery. Two grafts were lost early due to thrombosis of the venous drainage of the transplant; 4 grafts were lost to acute rejection; 3 were lost to chronic rejection; and 1 patient died with a functioning pancreas. One-year graft survival for all pancreatic grafts is 62 per cent. One-year patient survival is 96 per cent. One-year pancreatic graft and patient survival for the 14 combined kidney-pancreas transplants is 88 per cent and 100 per cent, respectively. Two kidneys transplanted with pancreata also were lost to acute rejection. Pancreas transplantation has proven to be a viable treatment alternative for selected patients with Type I diabetes mellitus. Long-term results are best when pancreas transplantation is done in combination with renal transplantation.
authors.affiliation: Department of Surgery, University of Louisville, School of Medicine, KY 40202.
authors.forename: F R
authors.initials: FR
authors.lastname: Bentley
authors.forename: R N
authors.initials: RN
authors.lastname: Garrison
mesh_terms: D000328:Adult; D001424:Bacterial Infections / Q000209:etiology; D003559:Cystostomy / Q000009:adverse effects / Q000379:methods; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery; D004385:Duodenostomy / Q000009:adverse effects / Q000379:methods; D005260:Female; D006083:Graft Occlusion, Vascular / Q000209:etiology; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000379:methods*; D008297:Male; D016035:Pancreas Transplantation / Q000009:adverse effects / Q000379:methods*; D011169:Portal Vein; D012086:Reoperation; D015996:Survival Rate; D013927:Thrombosis / Q000209:etiology; D016896:Treatment Outcome